BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3705190)

  • 1. Flow cytometrically determined DNA content of breast carcinoma and benign lesions: correlations with histopathological parameters.
    Uccelli R; Calugi A; Forte D; Mauro F; Polonio-Balbi P; Vecchione A; Vizzone A; De Vita R
    Tumori; 1986 Apr; 72(2):171-7. PubMed ID: 3705190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
    de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
    Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors.
    Longin A; Fontanière B; Pinzani V; Catimel G; Souchier C; Clavel M; Chauvin F
    Pathol Res Pract; 1992 Jun; 188(4-5):466-72. PubMed ID: 1409073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions.
    Spyratos F; Briffod M; Gentile A; Brunet M; Brault C; Desplaces A
    Anal Quant Cytol Histol; 1987 Dec; 9(6):485-94. PubMed ID: 3435626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA distributions in human normal, precancerous and cancerous breast tissue. I. Ploidy and cell cycle distribution.
    Weiss H; Kunde D; Streller B
    Arch Geschwulstforsch; 1986; 56(5):373-9. PubMed ID: 3021084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA aneuploidy and cell proliferation in breast tumors.
    Christov K; Milev A; Todorov V
    Cancer; 1989 Aug; 64(3):673-9. PubMed ID: 2743262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric DNA analyses of benign breast lesions detected by screening mammography.
    Stomper PC; DeBloom JR; Budnick RM; Stewart CC
    Clin Cancer Res; 1998 Jun; 4(6):1543-7. PubMed ID: 9626475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
    Leers MP; Nap M
    Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.
    Teodori L; Tirindelli-Danesi D; Mauro F; De Vita R; Uccelli R; Botti C; Modini C; Nervi C; Stipa S
    Cytometry; 1983 Sep; 4(2):174-83. PubMed ID: 6313307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric detection of multifocal DNA aneuploid cell populations in mastectomy specimens containing a primary breast carcinoma.
    van Dam PA; Van Bockstaele DR; Keersmaeckers GH; Uyttenbroeck FL
    Cytometry; 1990; 11(2):300-7. PubMed ID: 2318083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.
    Meyer JS; Coplin MD
    Am J Clin Pathol; 1988 May; 89(5):586-95. PubMed ID: 3358366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
    Dawson AE; Norton JA; Weinberg DS
    Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy in intraductal breast carcinomas.
    Aasmundstad TA; Haugen OA
    Eur J Cancer; 1990; 26(9):956-9. PubMed ID: 2177615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
    Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical breast carcinoma cell kinetics: review and update.
    Meyer JS; McDivitt RW; Stone KR; Prey MU; Bauer WC
    Breast Cancer Res Treat; 1984; 4(2):79-88. PubMed ID: 6378283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
    Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
    Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.